Manu Anantpadma Selected Research

Antiviral Agents (Antivirals)

9/2022	Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization.
2/2022	Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo.
11/2019	Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
1/2015	Interferon-γ Inhibits Ebola Virus Infection.
1/2015	Machine learning models identify molecules active against the Ebola virus in vitro.
2/2012	siRNA-mediated suppression of Japanese encephalitis virus replication in cultured cells and mice.
5/2010	Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manu Anantpadma Research Topics

Disease

14	Infections 09/2022 - 05/2010
7	Ebola Hemorrhagic Fever 01/2021 - 01/2015
3	Filoviridae Infections 10/2022 - 01/2016
2	COVID-19 09/2022 - 02/2022
2	Malaria 11/2019 - 01/2015
1	Marburg Virus Disease 10/2022
1	Disease Progression 02/2022
1	Vesicular Stomatitis 10/2018
1	Neoplasms (Cancer) 01/2015
1	Hypoxia (Hypoxemia) 01/2015

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 09/2022 - 05/2010
4	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2011
3	pyronaridineIBA 01/2020 - 01/2015
1	Peptides (Polypeptides)IBA 10/2022
1	Therapeutic UsesIBA 10/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Proline (L-Proline)FDA Link 01/2021
1	Heterogeneous-Nuclear Ribonucleoprotein LIBA 01/2021
1	Viral RNAIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	ChemokinesIBA 11/2019
1	ArtesunateIBA 11/2019
1	Antimalarials (Antimalarial Agents)IBA 11/2019
1	Immunologic Factors (Immunomodulators)IBA 11/2019
1	CytokinesIBA 11/2019
1	Monoclonal AntibodiesIBA 11/2018
1	Dihydroorotate DehydrogenaseIBA 10/2018
1	N- ((1R)- 6- chloro- 2,3,4,9- tetrahydro- 1H- carbazol- 1- yl)- 2- pyridinecarboxamideIBA 10/2018
1	brequinarIBA 10/2018
1	VaccinesIBA 01/2018
1	Complement System Proteins (Complement)IBA 03/2016
1	Immunoglobulins (Immunoglobulin)IBA 03/2016
1	ethylisopropylamiloride (EIPA)IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2015
1	RNA (Ribonucleic Acid)IBA 01/2015
1	Tilorone (Tilorone Hydrochloride)IBA 01/2015
1	Bulk DrugsIBA 01/2015
1	InterferonsIBA 01/2015
1	Small Interfering RNA (siRNA)IBA 02/2012

Therapy/Procedure

6	Therapeutics 02/2022 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2016